Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 551-560

  Wasik, Mariusz A ^a   Nowak, Irena ^a   Zhang, Qian ^a   Shaw, Leslie M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Jak3; Octylamino undecyl dimethylxanthine; Phosphorylation; Proliferation; STAT5; Suppression

Indexed keywords

CT 2576; CT 5589; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; PROTEIN KINASE; STAT5 PROTEIN; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

EID: 0031898875     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058363     Document Type: Article

References (49)

1. Minami, Y., Kono, T., Miyazaki, T. and Taniguchi, T. (1993). The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol, 11, 245-268.
2. Sugamura, K. (1994). Structure and function of IL-2 receptor subunits. Hum Cell, 7, 1-5.
3. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. and Silvennoinen, O. (1995). Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol, 13, 369-398.
4. Taniguchi, T. (1996). Cytokine signaling through nonreceptor protein tyrosine kinases. Science, 268, 251-255.
5. Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y. O., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W. and O'Shea, J. J. (1994). Phosphorylation and activation of the JAK3 Janus kinase in response to IL-2. Nature, 370, 151-153.
6. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Lui, E. T. and Ihle, J. N. (1994). Involvement of the JAK3 Janus kinase in IL-2 and IL-4 signalling in lymphoid and myeloid cells. Nature, 370, 153-157.
7. Beadling, C., Guschin, D., Witthuhn, B. A., Ziemiecki, A., Ihle, J. N., Kerr, I. M. and Cantrell, D. A. (1994). Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T-lymphocytes. EMBO J, 13, 5605-5615.
8. Lin, J.-X., Migone, T.-S., Tsang, M., Friedman, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S. and Leonard, W. J. (1995). The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity, 2, 331-339.
9. Fuji, H., Nakagawa, Y., Schinkdler, U., Kawahara, A., Mori, H., Gouilleux, F., Groner, B., Ihle, J. N., Minami, Y., Miyazaki, T. and Taniguchi, T. (1995). Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA, 92, 5482-5486.
10. Nielsen, M., Svejgard, S., Skov, N. and Odum, N. (1994). Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol, 24, 3082-3086.
11. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K. and Sugamura, K. (1993). Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science, 262, 1874-1877.
12. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E. and Leonard, W. J. (1993). Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science, 262, 1880-1883.
13. Noguchi, M., Nakamura, Y., Russel, S. M., Ziegler, S. F., Tsang, M., Cao, X. and Leonard, W. J. (1993). Interleukin-2 receptor γ chain: a functional component of the interleukin-7 receptor. Science, 262, 1877-1880.
14. Kimura, Y., Takeshita, T., Kondo, M., Ishii, N., Nakamura, M., Van Snick, J. and Sugamura, K. (1995). Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex. Int Immunol, 7, 115-120.
15. Grabstein, M., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenbron, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D., Anderson, D. M. and Giri, J. G. (1994). Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science, 264, 965-968.
16. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E. and Waldmann, T. A. (1994). The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA, 91, 4940-4944.
17. Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Shea, J. J., Vezzoni, P. and Notarangelo, L. D. (1995). Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 377, 65-68.
18. Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., O'Shea, J. J. and Leonard, W. J. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science, 270, 797-800.
19. Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H. and Berg, L. J. (1995). Defects in B lymphocyte maturation and T-lymphocyte activation in mice lacking Jak3. Science, 270, 794-797.
20. Nosaka, T., VanDeursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, A., McMickle, A. P., Doherty, P. C., Grosveld, G. C. and Ihle, J. N. (1995). Defective lymphoid development in mice lacking Jak3. Science, 270, 800-802.
21. Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W. and Leonard, W. J. (1993). Interleukin-2 receptor γ chain mutations result in X-linked severe combined immunodeficiency in humans. Cell, 73, 147-157.
22. Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsals, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., Paul, W. E., Katz, S. I., Love, P. I. and Leonard, W. J. (1995). Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity, 2, 223-238.
23. DiSanto, J. P., Muller, W., Guy-Grand, D., Fischer, A. and Rajewsky, K. (1995). Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA, 92, 377-381.
24. Ohbo, K., Suda, T., Hashiyama, M., Mantani, A., Ikebe, M., Miyakawa, K., Moriyama, M., Nakamura, M., Katsuki, M., Takahashi, K., Yamamura, K. and Sugamura, K. (1996). Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. Blood, 87, 956-967.
25. Ihle, J. N. (1996). STATs: signal transducers and activators of transcription. Cell, 84, 331-334.
26. Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C., Grosveld, G. C. and Ihle, J. N. (1996). Requirement for STAT4 in interleukin-12-mediated responses of natural killer and T cells. Nature, 382, 171-177.
27. Kaplan, M. H., Sun, Y. L., Hoey, T. and Grusby, M. J. (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature, 382, 174-177.
28. Migone, T.-S., Lin, J.-X., Creseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G. and Leonard, W. J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science, 269, 79-81.
29. Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O'Shea, J. J. and Nerenberg, M. I. (1995). Constitutive activation of different Jak tyrosine kinases in human T-cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Cl Invest, 96, 1548-1555.
30. Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M. and Wasik, M. A. (1996). Activation of the Jak-STAT signal transduction pathway associated with IL-2R common g chain in malignant T-cells derived from patients with cutaneous anaplastic large T-cell lymphoma and Sezary Syndrome. Proc Natl Acad Sci USA, 93, 9148-9153.
31. Wasik, M. A., Seldin, D. C., Butmarc, J. R., Gertz, R., Marti, R., Maslinski, W. and Kadin, M. E. (1996). Analysis of IL-2, IL-4 and their receptors in clonally- related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leukemia and Lymphoma, 23, 125-136.
32. Marti, R., Wasik, M. A. and Kadin, M. E. (1996). Constitutive and selective secretion of GM-CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder. Cytokine, 8, 323-329.
33. Miyazaki, T., Liu, Z. J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M. and Taniguchi, T. (1995). Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell, 81, 223-231.
34. Sigal, N. H. and Dumont, F. J. (1992). Cyclosporin A, FK506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol, 10, 519-560.
35. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, A. S. (1995). Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids. Science, 270, 283-286.
36. Eardley, D. D. and Koshland, M. E. (1991). Glycosyl-phosphosphatidylinositol A candidate system for interleukin-2 signal transduction. Science, 251, 78-81.
37. Rice, G. C., Tino, W., Burstein, S. L., Valentine, M., Bianco, J. A. and Singer, J. W. (1993). Development of novel specific pharmacologic inhibitors of interleukin-2 (IL-2) signal transduction. Blood, 82, 189a.
38. Singer, J. W., Bursten, S. L. and Rice, G. C. (1994). Inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications. Exp Opin Invest Drugs, 3, 631-643.
39. Davis, T. H., Morton, C. C., Miller-Cassman, R., Balk, S. P. and Kadin, M. E. (1992). Hodgkin's disease, Lymphomatoid papulosis, and cutaneous T cell lymphoma derived from a common T cell clone. N Engl J Med, 326, 1115-1122.
40. Abrams, T., Lessin, S., Ghosh, S. K., Ju, W., Vonderheid, E. C., Nowell, P., Murphy, G., Elfenbein, B. and DeFreitas, E. (1991). A Clonal CD4-Positive T cell line established from the blood of a patient with Sezary Syndrome. J Invest Dermatol, 96, 31-37.
41. + T-cell subsets stimulated via CD3-TCR complex. J Immunol, 144, 3334-3340.
42. Eugui, E. M. and Allison, A. C. (1993). Immunosuppressive activity of mycophenolate mufetil. Ann NY Acad Sci, 685, 309-329.
43. Wu, J. C. (1994). Mycophenolate mofetil: molecular mechanisms of action. Persp Drug Disc Design, 2, 185-204.
44. David, M., Petricoin, E., Benjamin, C., Pine, R., Weber, M. J. and Larner, A. C. (1995). Requirement for MAP kinase (ERK2) activity in interferon a- and interferon b-stimlated gene expression through STAT proteins. Science, 269, 1721-1723.
45. Danial, N. N., Pernis, A. and Rothman, P. (1995). Jak-STAT signaling induced by the v-abl oncogene. Science, 269, 1875-1277.
46. Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter, S. C., Schwartz, J. and Jove, R. (1995). Enhanced DNA-binding activity of a Sta3-related protein in cells transformed by the Src oncoprotein. Science, 269, 81-83.
47. Jayaraman, T., Ondrias, K., Ondrasova, E. and Marks, A. R. (1996). Regulation of the inositol 1,4,5-triphosphate receptor by tyrosine phosphorylation. Science, 272, 1492-1494.
48. Sharfe, N., Dadi, H. K. and Roifman, C. M. (1995). Jak3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase. Blood, 86, 2077-2085.
49. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. and Roifman, C. M. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-648.